PBG BioPharma Inc. donates nearly 1 million hand sanitizer bottles to Canadian communities to aid in COVID-19 Response

LEDUC, AB, June 2, 2021 – PBG BioPharma Inc., a life science company committed to becoming a world leader in the development and manufacturing of evidence-based biopharmaceuticals, nutraceuticals and medicinal cannabis products using its proprietary GenBioChem® Triple Fingerprinting Technology platform, has donated nearly 1 million bottles of hand sanitizers to Canadians country-wide. 

Albertans and Ontarians are among those hit hardest by the COVID-19 pandemic, with cases steadily creeping upwards since the onset of the virus and reaching some of the highest numbers per capita across all the provinces. Many outreach programs in the country found themselves in desperate need of supplies for their communities. PBG’s hand sanitizer donations went towards supplying these critical outreach centres, including seniors care associations, government organizations, churches, youth organizations, the Edmonton Food Bank, and homeless shelters. 

“We would like to acknowledge your generous in-kind donation of 7200 bottles of 60 ml hand sanitizers to Circle of Care,” said Carey Lucki, Chief Executive Officer of Circle of Care, Sinai Health. “On behalf of the Board of Directors, the staff and most importantly our clients & staff who will directly benefit from your support and generosity, thank you.” 

“Thank you so much for your recent donation of 3049 kg of hand sanitizer,” said Marjorie Benez, Executive Director of Edmonton’s Food Bank. “Your support plays a crucial role in our ability to provide food hampers […] for those in need.”

“We would like to recognize all of the hard-working employees and volunteers that continue to risk their lives to support these crucial communities,” said Dr. Jacqueline Shan, President and CEO of PBG BioPharma. “PBG is honored to have a hand in helping these organizations continue their work during this critical time and be part of the solution in battling the COVID-19 pandemic and the recovery effort in Canada.”

 

About PBG BioPharma

PBG BioPharma is a vertically integrated biopharmaceutical company focusing on the research and development, testing and manufacturing of nutraceuticals and biopharmaceuticals including science-based Cannabis products. Using its proprietary GenBioChem® Triple Fingerprinting Technology platform, the company takes a pharmaceutical approach to its product development, testing and manufacturing process. PBG BioPharma’s products are vigorously tested and standardized by chemical, biological and genomic fingerprinting to ensure product consistency, traceability, purity and potency batch-to-batch and are in compliance with or exceed regulatory standards.  PBG BioPharma is currently conducting research and development in the areas of immunotherapy, broad-spectrum anti-viral therapy, neuropathic pain and other neurological disorder management.  PBG BioPharma’s products, including Allergy Rf®, GenBioChem® Immunity and GenBioChem® Memory, are sold via multi-platform channels both nationally and internationally, including through its subsidiary retail pharmacy store, PBG Pharmacy/Chi Health Pharmacy.

Author avatar
Victoria Todhunter
http://pbgbiopharma.com